Search studies
7 studies found
203167 Phase 2a in Psoriasis
ELU-4-EA431B-1
Psoriasis Phase 2a clinical study.
BI Immuno-stimulant study
ELU-4-61FD55-1
BI Immuno-stimulant study
IL-2 Hepatotox-Cohort
TEST-4-D3F6E0-1
In vitro assays to identify IL-2 mediated hepatotoxicity
PEI HUVEC-characterization study
ELU-4-4238C7-1
Within a broad characterization study, we analyzed activation, viability, cytokine secretion, and permeability of human umbilical vein endothelial cells (HUVECs) upon stimulation with different stimuli. In addition HUVEC-permeability was analyzed in a trans-well-based leakage assay upon stimulation in presence or absence of human peripheral blood mononuclear cells (PBMCs).
PRECISESADS: Cross Sectional Study & Inception Cohort
ELU-4-9E5405-1
The goal of this project is to use the power of OMICs, and bioinformatics to identify new classifications for diseases known to share common pathophysiological mechanisms. Such knowledge has not been applied to individual patients, depriving them of potential benefits in terms of the use of new therapeutic agents that are being developed for one disease but cannot be applied in another, due to current clinical classifications. We will investigate individuals with systemic lupus erythematosus ...
Pfizer (NCT02958865)
ELU-4-B16B4B-1
The Pfizer UC dataset represents baseline, placebo and treatment (PF-06700841) subject and sample-level data extracted from a phase 2 study in moderate to severe ulcerative colitis.
Roche Immunomics study
ELU-4-B07C26-1
Roche Immunomics study
